doxepin has been researched along with Mouth Diseases in 1 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Mouth Diseases: Diseases involving the MOUTH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hetland, L | 1 |
| Woie, L | 1 |
1 other study available for doxepin and Mouth Diseases
| Article | Year |
|---|---|
[Diseases of teeth, periodontium and oral mucosa as side effects of anticholinergic drugs].
Topics: Adult; Dental Caries; Doxepin; Female; Gingival Diseases; Humans; Male; Methotrimeprazine; Middle Ag | 1975 |